Step by Stepa HemeOncBuddy patient portal

Alpelisib

Illustration: Alpelisib

Say it: al-peh-LIS-ib · Brand names: Piqray

Alpelisib is a targeted therapy pill that blocks a growth signal in breast cancers with a PIK3CA gene change.

What it is

Some breast cancers have a change in a gene called PIK3CA. This change makes a protein called PI3K stay turned on, which tells cancer cells to grow. Alpelisib blocks this protein and is given with fulvestrant.

Often used for

How you get it

Alpelisib is a pill you take by mouth at home, once a day with food. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Alpelisib?
Alpelisib is a targeted therapy pill that blocks a growth signal in breast cancers with a PIK3CA gene change. Brand names: Piqray.
What is Alpelisib used for?
hormone receptor positive, HER2 negative breast cancer with a PIK3CA gene change that is advanced or has spread, given with fulvestrant.
How is Alpelisib given?
Alpelisib is a pill you take by mouth at home, once a day with food. Your schedule may be different.
What are the common side effects of Alpelisib?
High blood sugar, which is very common. Diarrhea. Rash. Feeling sick to your stomach or throwing up. Feeling tired or weak. Not feeling hungry or losing weight. Mouth sores. Hair thinning.
When should I call my care team while taking Alpelisib?
Signs of high blood sugar, such as feeling very thirsty, peeing a lot, or feeling confused; Fruity smelling breath, belly pain, or fast breathing; A rash with blisters, peeling skin, or sores in your mouth or eyes; Swelling of your face or throat, or trouble breathing after a dose; New or worse cough, chest pain, or trouble breathing; Diarrhea that does not get better with the medicine your team gave you, or more than 4 to 6 loose stools in a day.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.